AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022

07 فبراير 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance

10 يناير 2022 07:00:02 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 يناير 2022 07:00:01 بحسب Nasdaq GlobeNewswire

European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease

03 ديسمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference

24 نوفمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations at the 14th International Congress of Inborn Errors of Metabolism

22 نوفمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease

18 نوفمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference

11 نوفمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates

09 نوفمبر 2021 07:00:04 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021

03 نوفمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire

U.S. FDA Accepts Filings for Amicus’ AT-GAA for the Treatment of Pompe Disease

29 سبتمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”

29 سبتمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations at the 26th International Annual Congress of the World Muscle Society

20 سبتمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021

03 سبتمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease

02 أغسطس 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

27 يوليو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors

14 يونيو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

28 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases

21 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

10 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire